FULC · Fulcrum Therapeutics, Inc.
$3.74
+0.03 (+0.81%)
At close · Aug 14
Market Cap
$285.35M
Shares
76.30M
Fulcrum Therapeutics, Inc. Earnings Call Transcripts
Every quarterly earnings call for Fulcrum Therapeutics, Inc. (FULC) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲19.7%
$5.06M
−$23.48M
'21 Q4
22-03-03
▼45.9%
$2.59M
−$25.93M
'22 Q1
22-05-09
▼57%
$1.88M
−$34.07M
'22 Q2
22-08-11
▼76%
$1.18M
−$23.74M
'22 Q3
22-11-08
▼88.6%
$295,000
−$24.78M
'23 Q1
23-05-15
▼53.2%
$880,000
−$23.78M
'23 Q2
23-08-03
▼35.8%
$759,000
−$24.02M
'23 Q3
23-11-07
▲27.2%
$871,000
−$24.76M
'23 Q4
24-02-27
▼100%
$
−$26.87M
'24 Q1
24-05-13
▲8990.9%
$80.00M
$55.41M
'24 Q2
24-07-31
▼100%
$
−$21.70M
'24 Q3
24-11-13
▼100%
$
−$16.57M
'24 Q4
25-02-25
LATEST
▼100%
$
−$17.30M
'25 Q2
25-07-29
Earnings call
FY26 · Q1
2026-04-27
Fulcrum Therapeutics, Inc. Q1 FY2026 Earnings Call
Confident tone
Next trial design and FDA end-of-Phase meeting
Global development and EMA engagement
Combination strategy with hydroxyurea and other mechanisms
Diluted EPS
$-0.25
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
Fulcrum Therapeutics, Inc. Q4 FY2025 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q2
2025-07-29
Fulcrum Therapeutics, Inc. Q2 FY2025 Earnings Call
Revenue
$
▼ 100% YoY Diluted EPS
$-0.28
▼ 132.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-01
Fulcrum Therapeutics, Inc. Q1 FY2025 Earnings Call
Diluted EPS
$-0.28
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-25
Fulcrum Therapeutics, Inc. Q4 FY2024 Earnings Call
Revenue
$*
▼ 100% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-13
Fulcrum Therapeutics, Inc. Q3 FY2024 Earnings Call
Revenue
$
▼ 100% YoY Diluted EPS
$-0.35
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-31
Fulcrum Therapeutics, Inc. Q2 FY2024 Earnings Call
Revenue
$80.00M
▲ 8990.9% YoY Diluted EPS
$0.87
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-13
Fulcrum Therapeutics, Inc. Q1 FY2024 Earnings Call
Revenue
$
▼ 100% YoY Diluted EPS
$-0.43
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Fulcrum Therapeutics, Inc. Q4 FY2023 Earnings Call
Revenue
$871,000*
▲ 27.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Fulcrum Therapeutics, Inc. Q3 FY2023 Earnings Call
Revenue
$759,000
▼ 35.8% YoY Diluted EPS
$-0.39
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
Fulcrum Therapeutics, Inc. Q2 FY2023 Earnings Call
Revenue
$880,000
▼ 53.2% YoY Diluted EPS
$-0.38
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-15
Fulcrum Therapeutics, Inc. Q1 FY2023 Earnings Call
Revenue
$295,000
▼ 88.6% YoY Diluted EPS
$-0.41
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q3
2022-11-08
Fulcrum Therapeutics, Inc. Q3 FY2022 Earnings Call
Revenue
$1.18M
▼ 76% YoY Diluted EPS
$-0.51
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-11
Fulcrum Therapeutics, Inc. Q2 FY2022 Earnings Call
Revenue
$1.88M
▼ 57% YoY Diluted EPS
$-0.83
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-09
Fulcrum Therapeutics, Inc. Q1 FY2022 Earnings Call
Revenue
$2.59M
▼ 45.9% YoY Diluted EPS
$-0.64
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-03
Fulcrum Therapeutics, Inc. Q4 FY2021 Earnings Call
Revenue
$5.06M*
▲ 19.7% YoY
Rev · 6q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Fulcrum Therapeutics, Inc. Q3 FY2021 Earnings Call
Revenue
$4.93M
▲ 167% YoY Diluted EPS
$-0.57
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-10
Fulcrum Therapeutics, Inc. Q2 FY2021 Earnings Call
Revenue
$4.38M
▲ 119% YoY Diluted EPS
$-0.60
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Fulcrum Therapeutics, Inc. Q1 FY2021 Earnings Call
Revenue
$4.79M
▲ 538.5% YoY
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q3
2020-11-10
Fulcrum Therapeutics, Inc. Q3 FY2020 Earnings Call
Revenue
$1.85M
Rev · 3q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-11
Fulcrum Therapeutics, Inc. Q2 FY2020 Earnings Call
Revenue
$2.00M
Rev · 2q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-13
Fulcrum Therapeutics, Inc. Q1 FY2020 Earnings Call
Revenue
$750,000
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-05
Fulcrum Therapeutics, Inc. Q4 FY2019 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–23 of 23 earnings calls
Key facts
CIK
1680581
CUSIP
359616109
13F (30d)
152 filings
146 filers
Visit website
Investor relations